Unverified
Gathered automatically from the outlets below; our newsroom hasn't checked it yet.
DNA drug developer Seawolf launches with $100 million funding, Sanofi deal
Seawolf Therapeutics on Monday launched publicly with $100 million in funding and a deal with French drugmaker Sanofi worth up to $1.2 billion, as it seeks to develop DNA-based medicines.